Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Oracle
ORCL
|
$967M |
| 2 |
DoorDash
DASH
|
$472M |
| 3 |
Amgen
AMGN
|
$391M |
| 4 |
Amazon
AMZN
|
$304M |
| 5 |
Applied Materials
AMAT
|
$260M |
Top Sells
| 1 |
Abbott
ABT
|
$587M |
| 2 |
Workday
WDAY
|
$556M |
| 3 |
United Parcel Service
UPS
|
$458M |
| 4 |
Apple
AAPL
|
$413M |
| 5 |
Atlassian
TEAM
|
$383M |
Sector Composition
| 1 | Technology | 32.99% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Wayfair
W
$11.6B
| $110M | 0.06% |
1,627,712
+1,316,865
| +424% | +$89.4M |
|
252
S&P Global
SPGI
$164B
| $110M | 0.06% |
258,726
-17,574
| -6% | -$7.47M |
|
|
CHX
253
DELISTED
ChampionX
CHX
| $109M | 0.06% |
3,024,688
-262,735
| -8% | -$9.43M |
|
254
Mirion Technologies
MIR
$5.28B
| $107M | 0.06% |
9,403,114
+3,929
| +0% | +$44.7K |
|
255
PTC Therapeutics
PTCT
$4.55B
| $107M | 0.06% |
3,669,816
+1,057,223
| +40% | +$30.8M |
|
256
Cisco
CSCO
$264B
| $106M | 0.06% |
2,123,140
-3,169,118
| -60% | -$158M |
|
257
Arcellx
ACLX
$4.03B
| $106M | 0.06% |
1,522,309
-15,901
| -1% | -$1.11M |
|
258
Maximus
MMS
$4.97B
| $105M | 0.06% |
1,254,536
+25,825
| +2% | +$2.17M |
|
259
Western Alliance Bancorporation
WAL
$10B
| $104M | 0.06% |
1,617,291
-1,829
| -0.1% | -$117K |
|
260
Donaldson
DCI
$9.44B
| $104M | 0.06% |
1,389,144
-21,115
| -1% | -$1.58M |
|
261
Arista Networks
ANET
$180B
| $103M | 0.06% |
1,420,660
-116,928
| -8% | -$8.47M |
|
262
BridgeBio Pharma
BBIO
$10.2B
| $102M | 0.06% |
3,312,706
+2,169,143
| +190% | +$67.1M |
|
263
4D Molecular Therapeutics
FDMT
$340M
| $102M | 0.06% |
3,197,444
+104,148
| +3% | +$3.32M |
|
264
Regal Rexnord
RRX
$9.66B
| $101M | 0.06% |
560,701
-580,853
| -51% | -$105M |
|
265
Regeneron Pharmaceuticals
REGN
$60.8B
| $100M | 0.05% |
103,992
-8,837
| -8% | -$8.5M |
|
266
UBS Group
UBS
$128B
| $100M | 0.05% |
3,247,489
-158,839
| -5% | -$4.89M |
|
267
Advanced Drainage Systems
WMS
$11.5B
| $98.8M | 0.05% |
573,217
-16,886
| -3% | -$2.91M |
|
268
NeoGenomics
NEO
$1.03B
| $98.7M | 0.05% |
6,280,866
-67,747
| -1% | -$1.06M |
|
269
AvalonBay Communities
AVB
$27.8B
| $96.8M | 0.05% |
521,815
+29,953
| +6% | +$5.56M |
|
270
Clarivate
CLVT
$2.96B
| $95.8M | 0.05% |
12,900,281
+139,610
| +1% | +$1.04M |
|
271
Trip.com Group
TCOM
$47.6B
| $95.5M | 0.05% |
2,175,488
-40,517
| -2% | -$1.78M |
|
272
Shift4
FOUR
$6.01B
| $94.8M | 0.05% |
1,434,890
+255,741
| +22% | +$16.9M |
|
273
Amphenol
APH
$135B
| $94.3M | 0.05% |
1,634,340
+6,180
| +0.4% | +$356K |
|
274
3M
MMM
$82.7B
| $94.2M | 0.05% |
1,062,723
+967,462
| +1,016% | +$85.8M |
|
275
Crinetics Pharmaceuticals
CRNX
$3.35B
| $92.5M | 0.05% |
1,978,172
+1,434,909
| +264% | +$67.1M |
|